Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 11, 2006, Pages 2196-2202

  Peters, Edward S ^a   McClean, Michael D ^b   Marsit, Carmen J ^c   Luckett, Brian ^a   Kelsey, Karl T ^c  

^a Medical Center   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CARCINOGEN; CIGARETTE SMOKE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CATALYSIS; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PHARYNX CARCINOMA; PRIORITY JOURNAL; QUESTIONNAIRE; SQUAMOUS CELL CARCINOMA;

ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; MOUTH NEOPLASMS; PHARYNGEAL NEOPLASMS; POLYMORPHISM, GENETIC; QUESTIONNAIRES; REGRESSION ANALYSIS; SMOKING;

EID: 33845335871     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0503     Document Type: Article

References (57)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
3. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48:3282-7.
4. Day GL, Blot WJ, Austin DF, et al. Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco, and other determinants. J Natl Cancer Inst 1993;85:465-73.
5. Rothman K, Keller A. The effect of joint exposure to alcohol and tobacco on risk of cancer of the mouth and pharynx. J Chronic Dis 1972;25:711-6.
6. Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol 2006;7:149-56.
7. Wight AJ, Ogden GR. Possible mechanisms by which alcohol may influence the development of oral cancer - a review. Oral Oncology 1998;34:441-7.
8. Lai C, Shields PG. The role of interindividual variation in human carcinogenesis. J Nutr 1999;129:552-55S.
9. Strange RC, Fryer AA. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ 1999:231-49.
10. Brennan P, Boffetta P. Mechanistic considerations in the molecular epidemiology of head and neck cancer. In: Buffler P, Rice J, Baan R, Bird M, Boffetta P, editors. Mechanisms of carcinogenicity: contributions of molecular epidemiology. Lyon: International Agency for Research on Cancer; 2004. p. 393-414.
11. Geisler SA, Olshan AF. GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. Am J Epidemiol 2001;154:95-105.
12. Pari FF. Glutathione S-transferase genotypes and cancer risk. Cancer Lett 2005;221:123-9.
13. Ahmed AE, Anders MW. Metabolism of dihalomethanes to formaldehyde and inorganic halide. I. In vitro studies. Drug Metab Dispos 1976;4:357-61.
14. Laurie RD, Bercz JP, Wessendarp TK, Condie LW. Studies of the toxic interactions of disinfection by-products. Environ Health Perspect 1986;69:203-7.
15. Boorman GA. Drinking water disinfection byproducts: review and approach to toxicity evaluation. Environ Health Perspect 1999;107 Suppl 1:207-17.
16. Chopra N, Sherman L. Systematic studies on the breakdown p,p′-DDT in tobacco smokes. Anal Chem 1972;44:1036-8.
17. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88.
18. Wiencke JK, Kelsey KT, Lamela RA, Toscano WA, Jr. Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res 1990;50:1585-90.
19. Wiencke JK, Pemble S, Ketterer B, Kelsey KT. Gene deletion of glutathione S-transferase θ: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 1995;4:253-9.
20. Seidegard J, Pero RW, Markowitz MM, Roush G, Miller DG, Beattie EJ. Isoenzyme(s) of glutathione transferase (class μ) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis 1990;11:33-6.
21. Duell EJ, Holly EA, Bracci PM, Liu M, Wiencke JK, Kelsey KT. A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J Natl Cancer Inst 2002;94:297-306.
22. Nelson HH, Wiencke JK, Christiani DC, et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase θ. Carcinogenesis 1995;16:1243-5.
23. Smith CM, Kelsey KT, Wiencke JK, Leyden K, Levin S, Christiani DC. Inherited glutathione-S-transferase deficiency is a risk factor for pulmonary asbestosis. Cancer Epidemiol Biomarkers Prev 1994;3:471-7.
24. Kelsey KT, Spitz MR, Zuo ZF, Wiencke JK. Polymorphisms in the glutathione S-transferase class μ and θ genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States). Cancer Causes Control 1997;8:554-9.
25. Karagas MR, Park S, Warren A, et al. Gender, smoking, glutathione-S-transferase variants, and bladder cancer incidence: a population-based study. Cancer Lett 2005;219:63-9.
26. Engel LS, Taioli E, Pfeiffer R, et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 2002;156:95-109.
27. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733-43.
28. Jourenkova-Mironova N, Voho A, Bouchardy C, et al. Glutathione S-transferase GSTM1, GSTM3, GSTP1, and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers. Int J Cancer 1999;81:44-8.
29. Olshan AF, Weissler MC, Watson MA, Bell DA. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2000;9:185-91.
30. Hashibe M, Brennan P, Strange RC, et al. Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2003;12:1509-17.
31. Peters ES, McClean MD, Liu M, Eisen EA, Mueller N, Kelsey KT. The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. Cancer Epidemiol Biomarkers Prev 2005;14:476-82.
32. Cheng T, Christiani D, Xu X, Wain J, Wiencke J, Kelsey K. Glutathione S-transferase μ genotype, diet, and smoking as determinants of sister chromarid exchange frequency in lymphocytes. Cancer Epidemiol Biomarkers Prev 1995;4:535-42.
33. Wrensch M, Kelsey KT, Liu M, et al. Glutathione-S-transferase variants and adult glioma. Cancer Epidemiol Biomarkers Prev 2004;13:461-7.
34. Blot WJ, Devesa SS, McLaughlin JK, Fraumeni JF, Jr. Oral and pharyngeal cancers. Cancer Surv 1994;19-20:23-42.
35. Mashberg A, Boffetta P, Winkelman R, Garfinkel L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 1993;72:1369-75.
36. Winn DM, Blot WJ, McLaughlin JK, et al. Mouthwash use and oral conditions in the risk of oral and pharyngeal cancer. Cancer Res 1991;51:3044-7.
37. Olshan AF, Watson MA, Weissler MC, Bell DA. XRCC1 polymorphisms and head and neck cancer. Cancer Lett 2002;178:181-6.
38. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons; 1989.
39. Rothman KJ, Greenland S. Modern epidemiology. Philadelphia: Lippincott-Raven; 1998.
40. Hayes RB, Bravo-Otero E, Kleinman DV, et al. Tobacco and alcohol use and oral cancer in Puerto Rico. Cancer Causes Control 1999;10:27-33.
41. To-Figueras J, Gene M, Gomez-Catalan J, et al. Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk. Cancer Lett 2002;187:95-101.
42. Oude Ophuis MB, Manni JJ, Peters WH. Glutathione S-transferase T1 null polymorphism and the risk for head and neck cancer. Acta Otolaryngol 2006;126:311-7.
43. Jaskula-Sztul R, Reinikainen M, Husgafvel-Pursiainen K, Szmeja W, Tof K, Hirvonen S. Glutathione S transferase M1 and T1 genotypes and susceptibility to smoking related larynx cancer. Biomarkers 1998;3:149-55.
44. Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1, and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res 2005;574:112-23.
45. Hanna E, MacLeod S, Vural E, Lang N. Genetic deletions of glutathione-S-transferase as a risk factor in squamous cell carcinoma of the larynx: a preliminary report. Am J Otolaryngol 2001;22:121-3.
46. Sugimura T, Kumimoto H, Tohnai I, et al. Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med 2006;35:11-8.
47. Huang K, Sandler RS, Millikan RC, Schroeder JC, North KE, Hu J. GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a population-based case-control study in North Carolina (United States). Cancer Causes Control 2006;17:385-94.
48. Abbas A, Delvinquiere K, Lechevrel M, et al. GSTM1, GSTT1, GSTP1, and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: different pattern of squamous cell carcinoma and adenocarcinoma. World J Gastroenterol 2004;10:3389-93.
49. Kelada SN, Kardia SL, Walker AH, Wein AJ, Malkowicz SB, Rebbeck TR. The glutathione S-transferase-μ and -θ genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol Biomarkers Prev 2000;9:1329-34.
50. Landi S. Mammalian class θ GST and differential susceptibility to carcinogens: a review. Mutat Res 2000;463:247-83.
51. Lof A, Johanson G, Rannug A, Warholm M. Glutathione transferase T1 phenotype affects the toxicokinetks of inhaled methyl chloride in human volunteers. Pharmacogenetics 2000;10:645-53.
52. Matthias C, Bockmuhl U, Jahnke V, et al. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics 1998;8:91-100.
53. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000;61:154-66.
54. Squier CA, Cox P, Hall BK. Enhanced penetration of nitrosonornicotine across oral mucosa in the presence of ethanol. J Oral Pathol Med 1986;15:276-9.
55. Du X, Squier CA, Kremer MJ, Wertz PW. Penetration of N-nitrosonornicotine (NNN) across oral mucosa in the presence of ethanol and nicotine. J Oral Pathol Med 2000;29:80-5.
56. Howie NM, Trigkas TK, Cruchley AT, Wertz PW, Squier CA, Williams DM. Short-term exposure to alcohol increases the permeability of human oral mucosa. Oral Dis 2001;7:349-54.
57. Park JY, Muscat JE, Schantz SP, Stern JC, Richie JP, Jr., Lazarus P. Association between GSTM polymorphisms and risk for oral cancer in African Americans as compared to Caucasians. GSTM polymorphisms and oral cancer risk 1999.